{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:24:49Z","timestamp":1780424689125,"version":"3.54.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\nBackground<\/jats:title>\nChronic hepatitis B virus (HBV) infection is a significant global health issue, leading to liver-related morbidity and mortality. The systemic immune-inflammation index (SII), a marker of systemic inflammation and immune response, may predict disease outcomes. However, its role in HBV infection and its relationship with HBV surface antibody (HBsAb) status is not well understood. This study investigates the association between SII, HBsAb status, and their combined effects on all-cause and cardiovascular disease (CVD) mortality.<\/jats:p>\n<\/jats:sec>\n\nMethods<\/jats:title>\nWe analyzed data from 43,539 participants in the National Health and Nutrition Examination Survey (NHANES), categorizing them into four groups based on SII and HBsAb status: high\/low SII with HBsAb-negative\/positive. Mortality outcomes were assessed using Cox proportional hazards models adjusted for age, sex, race\/ethnicity, BMI, and comorbidities.<\/jats:p>\n<\/jats:sec>\n\nResults<\/jats:title>\nIn the analysis of 43,539 participants, the fully adjusted model revealed that SII was significantly associated with both all-cause mortality (HR\u2009=\u20091.138, p\u2009<\u20090.001) and cardiovascular disease mortality (HR\u2009=\u20091.402, p\u2009<\u20090.0001), indicating that higher SII independently increases the risk of both outcomes. While the crude model showed a protective effect of HBV surface antibody on all-cause mortality (HR\u2009=\u20090.491, p\u2009<\u20090.0001) and cardiovascular disease mortality (HR\u2009=\u20090.478, p\u2009<\u20090.0001), this effect diminished after full adjustment. Additionally, the combined effect of SII and HBV surface antibody on both mortality outcomes remained significant in the fully adjusted model (HR\u2009=\u20091.402, p\u2009<\u20090.0001).<\/jats:p>\n<\/jats:sec>\n\nConclusion<\/jats:title>\nHigher SII is independently associated with increased risks of all-cause and cardiovascular disease mortality. The protective effect of HBV surface antibody on mortality diminished after adjustment for confounders. The combined effect of SII and HBV surface antibody on mortality highlights the complex interaction between inflammation and immune response in chronic HBV infection. SII may serve as a useful predictor of long-term health risks in HBV-infected individuals.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0328400","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:33:31Z","timestamp":1753119211000},"page":"e0328400","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study"],"prefix":"10.1371","volume":"20","author":[{"given":"Di","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nansheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianze","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8669-5634","authenticated-orcid":true,"given":"Jiong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"9","key":"pone.0328400.ref001","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"pone.0328400.ref002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","article-title":"Hepatitis B vaccines: WHO position paper--recommendations","volume":"28","author":"WHO Publication","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"pone.0328400.ref003","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"HB El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0328400.ref004","doi-asserted-by":"crossref","first-page":"100623","DOI":"10.1016\/j.jhepr.2022.100623","article-title":"Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries","volume":"5","author":"T Mitchell","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"pone.0328400.ref005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease","volume":"20","author":"NP Nelson","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"4","key":"pone.0328400.ref006","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cancers16040777","article-title":"Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma","volume":"16","author":"N Varghese","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"23","key":"pone.0328400.ref007","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"B Hu","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"8","key":"pone.0328400.ref008","article-title":"Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab","volume":"33","author":"J Liu","year":"2019","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"pone.0328400.ref009","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.32303","article-title":"The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study","volume":"146","author":"J Fest","year":"2020","journal-title":"Int J Cancer"},{"key":"pone.0328400.ref010","doi-asserted-by":"crossref","first-page":"537140","DOI":"10.3389\/fonc.2021.537140","article-title":"Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis","volume":"11","author":"Y Qiu","year":"2021","journal-title":"Front Oncol"},{"issue":"15","key":"pone.0328400.ref011","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.3390\/ijms25158441","article-title":"Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)","volume":"25","author":"O Menyhart","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0328400.ref012","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1097\/JS9.0000000000000741","article-title":"Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: a retrospective cohort study","volume":"109","author":"Y Wu","year":"2023","journal-title":"Int J Surg"},{"issue":"14","key":"pone.0328400.ref013","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.7150\/jca.30281","article-title":"Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma","volume":"10","author":"Y Gao","year":"2019","journal-title":"J Cancer"},{"issue":"8","key":"pone.0328400.ref014","article-title":"Immune Response in Hepatitis B Virus Infection","volume":"5","author":"A Tan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"pone.0328400.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7774\/cevr.2020.9.1.1","article-title":"Hepatitis B vaccination and immunotherapies: an update","volume":"9","author":"C Stasi","year":"2020","journal-title":"Clin Exp Vaccine Res"},{"key":"pone.0328400.ref016","doi-asserted-by":"crossref","first-page":"893512","DOI":"10.3389\/fimmu.2022.893512","article-title":"Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection","volume":"13","author":"S Wu","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0328400.ref017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.29082","article-title":"Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis","volume":"66","author":"S Paul","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"pone.0328400.ref018","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2893.2009.01144.x","article-title":"Virological and clinical characteristics of delta hepatitis in Central Europe","volume":"16","author":"B Heidrich","year":"2009","journal-title":"J Viral Hepat"},{"issue":"7","key":"pone.0328400.ref019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/v10070363","article-title":"HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets","volume":"10","author":"L Colagrossi","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"pone.0328400.ref020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12889-025-21423-1","article-title":"Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005-2018","volume":"25","author":"S Wu","year":"2025","journal-title":"BMC Public Health"},{"key":"pone.0328400.ref021","doi-asserted-by":"crossref","first-page":"102536","DOI":"10.1016\/j.pmedr.2023.102536","article-title":"The association of systemic inflammatory biomarkers with non-alcoholic fatty liver disease: a large population-based cross-sectional study","volume":"37","author":"W Sun","year":"2023","journal-title":"Prev Med Rep"},{"issue":"18","key":"pone.0328400.ref022","doi-asserted-by":"crossref","first-page":"338","DOI":"10.21037\/atm.2016.09.11","article-title":"Diagnosis of hepatitis B","volume":"4","author":"JE Song","year":"2016","journal-title":"Ann Transl Med"},{"issue":"9","key":"pone.0328400.ref023","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1478-3231.2012.02831.x","article-title":"HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome","volume":"32","author":"B Heidrich","year":"2012","journal-title":"Liver Int"},{"issue":"6","key":"pone.0328400.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004930","article-title":"Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers","volume":"11","author":"E Martin-Gayo","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"pone.0328400.ref025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50310","article-title":"Kinetics of the immune response during HBV and HCV infection","volume":"38","author":"A Bertoletti","year":"2003","journal-title":"Hepatology"},{"issue":"9","key":"pone.0328400.ref026","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/pathogens13090766","article-title":"Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies","volume":"13","author":"A Quirino","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"pone.0328400.ref027","doi-asserted-by":"crossref","first-page":"2445283","DOI":"10.1080\/21645515.2024.2445283","article-title":"The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus","volume":"21","author":"L Ding","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0328400.ref028","doi-asserted-by":"crossref","first-page":"112350","DOI":"10.1016\/j.exger.2023.112350","article-title":"Relationship between systemic immune inflammation index and mortality among US adults with different diabetic status: Evidence from NHANES 1999-2018","volume":"185","author":"Y Tang","year":"2024","journal-title":"Exp Gerontol"},{"issue":"3","key":"pone.0328400.ref029","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines12030288","article-title":"Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030","volume":"12","author":"SA Al-Busafi","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"pone.0328400.ref030","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"L Chen","year":"2017","journal-title":"Oncotarget"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:33:37Z","timestamp":1753119217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328400"}},"subtitle":[],"editor":[{"given":"Minh","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328400","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}